TABLE 2.
Immunophenotypic Profiles of Normal PDCs, “Tumor Forming” PDC Proliferations Associated With Myeloid Neoplasms, and BPDCN
| Antigen | Normal PDCs |
“Tumor forming” PDC Proliferations |
BPDCN |
|---|---|---|---|
| CD123 | + | + | + |
| TCL1 | + | + | + |
| CD4 | + | + | + |
| CD56 | −* | ±† | +‡ |
| TdT | − | − | ± |
| Ki-67 | <5% | < 10% | > 30% |
Positivity reported in a small subset of circulating PDCs.
Usually negative but may show focal positivity.
Negative cases extremely rare.
BPDCN indicates blastic plasmacytoid dendritic cell neoplasm; PDC, plasmacytoid dendritic cell; TCL, T-cell leukemia/lymphoma; TdT, terminal deoxynucleotidyl transferase.